Replies to post #183 on Blue Apron Holdings Inc (APRN)

[alchemytrader]

CLSD - 11.80 up 59.90% premarket on news. Big gap.


Clearside Biomedical announces positive topline results from its pivotal Phase 3 clinical trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis CLSD 

[alchemytrader]

CVRS - 1.18 up 12.38% premarket on news. low volume.


Corindus Vascular Robotics receives FDA clearance for first automated robotic movement in technIQ Series for CorPath GRX platform  CVRS